Loss of cell-cycle checkpoints in order to maximize low-dose radiation-induced inflammatory responses and sensitize ovarian cancer to immune checkpoint blockade therapy
Chemin de la Fauvette 61, 1012 Lausanne
MD, PhD Fernanda Herrera
CHF 190'000.00
Precision Oncology Targeting of Folic Acid Metabolism in Pediatric Osteosarcoma
University Children's Hospital Zürich, Steinwiesstrasse 75, 8032 Zürich
Dr. med. Univ. et Dr. phil Raphael Johannes Jonathan Morscher
CHF 241’738.00
Mitochondrial reprogramming to restore age-driven dysfunction in T cell and boost
CAR-T cell therapy
Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research Lausanne, Biopole 3 Chemin des Boveresses 155, 1066 Epalinges
PhD Nicola Vannini Group Leader
CHF 135’808.00
Characterization and optimization of small molecules able to restore PTEN physiological levels and/or activity in prostate cancer
Head Computational Structural Biology, Institute for Research in Biomedicine, Via
Vincenzo Vela 6, 6500 Bellinzona
Dr. Andrea Cavalli, PhD
CHF 160'600.00
TAXIS — Tailored Axillary Surgery
Brustchirurgie, Universitätsspital Basel, Spitalstrasse 21, 4031 Basel
Prof. Dr. Walter Weber
CHF 126'870.00
Transcriptional regulation of T cell lymphoma development
Institute for Research in Biomedicine, Via Vincenzo Vela 6, 6500 Bellinzona
PhD Silvia Monticelli
CHF 153'000.00
Advancing cancer immunotherapy with non-viral engineering of multifunctional CAR T cells
Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Ramistrasse 100, 8091 Zurich
PhD Assisant Professor Chiara Francesca Magnani
CHF 210'000.00
Mechanisms of cancer resistance to CAR-T cell therapy
Istituto di Ricerca in Biomedicina, Via Vincenzo Vela 6, 6500 Bellinzona
Prof. Dr. Roger Geiger
CHF 190'000.00
Use of lymphoma ex-vivo biopsies as a platform to anticipate individual response to therapies
Swiss Institute for Experimental Cancer Research EPFL, 1015 Lausanne
PhD, Associate Professor Elisa Oricchio
CHF 177’000.00
Differential role of IL-33 in colorectal cancer development
Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern
PD (Dr. Sc. Nat. ETHZ), Prof. Philippe Krebs
CHF 170’000.00
MET as a target for combined modality treatment of glioblastoma
Chairman University Hospital Zurich, Department of Neurology
Frauenklinikstrasse 26,
8091 Zurich (Switzerland)
Prof. Dr. Michael Weller
CHF 250'000.00
Impact of the tyrosine kinase inihibitor disatinib on lymphoid tissue microenvironment and tumor cell niche
Dept. OMI, University of Fribourg
Ch. du Musee 5,
1700 Fribourg (Switzerland)
Prof. Jens V. Stein
CHF 187'289.00
Identifying the mode of action of the anti-tumor immune response induced by selected Clostridiales bacteria in colorectal cancer patients
Leiter Forschung, Leiter Translationales Mikrobiom Forschungszentrum
Universitatsspital Zurich, Klinik fur Gastroenterologie and Hepatologie
Ramistrasse 100,
8091 Zurich (Switzerland)
Prof. Dr. med. Michael Scharl
CHF 168'291.00
PREDICT — Peptide Radiotracers Enabling high-contrast PD-1 targeted Diagnostic Imaging of antigen-experienced T-cells for improved prediction of response to Immune Checkpoint targeted Therapies
Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Molecular Imaging, CHUV, Department of Oncology, UNIL, Centre Hospitalier Universitaire Vaudois (CHUV)
Agora, B25A/03/094
Rue du Bugnon 25A,
1011 Lausanne (Switzerland)
Prof. Dr. Margret Schottelius
CHF 216'000.00
Immunotherapy of breast carcinoma through combination of PLGA-microsphere based vaccination with immune checkpoint blockade
Biotechnology Institute Thurgau Unterseestrasse 47
8280 Kreuzlingen (Switzerland)
Prof.Dr. Marcus Groettrup
CHF 140'000.00
“Helping the Killers”: innovative cancer immunotherapy harnessing “quasi-universal” tumor-specific CD4 T cells
Targeting of Cytokine secreting lymphocyte (TCSL) group
Department of Oncology UNIL-CHUV and Ludwig Institute for Cancer Research Biopole III, Chemin des Boveresses 155
1066 Epalinges (Switzerland)
MD, Ph.D. Camilla Jandus-Marone SNSF Assistant Professor,
CHF 150’000.00
Analysis of the tumor immune signature and effect of immunotherapy in a mouse model of small cell lung cancer.
Ecole Polytechnique Federale de Lausanne, Station 19, 1015 Lausanne (Switzerland)
Etienne Meylan, PhD
CHF 70'000.00
Extracellular ATP as target in tumor environment to improve adaptive immunity.
Institute for Research in Biomedicine (IRB), Via Vela 6, 6500 Bellinzona (Switzerland)
Fabio Grassi, MD, PhD
CHF 162'000.00
Examination of the tumor environment to boost immunotherapy in pancreatic cancer.
Experimental Pathology, University of Bern, 3000 Bern (Switzerland)
Mirjam Schenk, PhD
CHF 143'000.00
Targeting chemoresistance and tumor microenvironment in colon cancer.
Division of Experimental Pathology, CHUV 1015 Lausanne (Switzerland)
Tatiana Petrova, PhD
CHF 87'000.00
A proof-of-concept, prospective, observational study to investigate the value of Liquid Biopsies to predict tumor response after neoadjuvant chemo-radiotherapy in patients with locally advanced Rectal Cancer: the LiBReCa study.
Institute of Pathology, 6600 Locarno (Switzerland)
Prof. Dr. med. Dimitri Christoforidis
CHF 158’000.00
The ethical communication of medical diagnosis and prognosis: a certificate of advanced studies (CAS) through Medical Humanities.
Fondazione Sasso Corbaro, 6500 Bellinzona (Switzerland)
Prof. Dr. med. Roberto Malacrida
CHF 10’000.00
Uncovering the T cell-intrinsic role of NLRC5 in antitumoral responses.
Department of Biochemistry, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges (Switzerland)
Greta Guarda, PhD,
CHF 153’140.00
TCR activation is compromised in CD8 T cells transduced with a Chimeric Antigen Receptor (CAR). Implications for CAR-T cell mediated immunotherapy.
Departement of Fundamental Oncology and Ludwig Center for Cancer
Research- Biopole 3, Ch.des Boveresses 155, 1066 Epalinges
(Switzerland)
Alena Donda PhD
CHF 65’000.00
Intravital study of the traffcking of B lymphoma cells in the lymphatic compartment.
IRB, Institute for Research in Biomedicine, Via Vela 6, 6500 Bellinzona (Switzerland)
Fernandez Gonzales Santiago PhD, PhD.
CHF 200’000.00
Understanding and targeting chemoresistance in colorectal cancer.
University of Lausanne and CHUV, Ch. Des Boveresses 155, 1066 Epalinges (Switzerland)
Tatiana Petrova PhD.
CHF 70’000.00
Modulation of colorectal cancer immune contexture by gut microbiota.
Universitätsspital Basel, Zentrum für Lehre und Forschung (ZLF),
Hebelstrasse 20, 4031 Basel (Switzerland)
Giandomenica Iezzi, PD Dr. med.
CHF 120'000.00
Dissecting the association of the human palatine tonsil microbiome and HPV-driven oropharyngeal squamous cell carcinoma
Institut für Immunbiologie
Rorschacher Strasse 95, Kantonspital St.Gallen (Switzerland)
Prof. Dr. Ludewig Burkhard
CHF 144’000.00
Novel Active Combinations Containing Bromodomain (BRD) and Extra-terminal (BET) Inhibitors for Patients with Germinal Center B-cell Type
Diffuse large B-cell lymphoma
Institute of Oncology Research, Via Vela 6, 6500 Bellinzona (Switzerland)
Eugenio Gaudio PhD
CHF 160’000.00
Role of BCL2 genetic heteroclonality in the pathogenesis of B-cell lymphomas with BCL2 rearrangement
Istituto Cantonale di Patologia, Via in Selva 24, 6600 Locarno (Switzerland)
Prof. Dr. Med. Luca Mazzucchelli
CHF 170’000.00
Oncogenic aversion: A concept towards new therapeutic avenues in prostate cancer
Institute of Oncology Research, Via Vela 6, 6500 Bellinzona (Switzerland)
Prof. Dr. med. Jean-Philippe Theurillat
CHF 170’000.00
Role of Notch signaling and therapeutic potential of exosomes in
cardiomyopathy induced by doxorubicin & trastuzumab cancer treatment
Cardiocentro Ticino, Via Tesserete 48, 6900 Lugano (Switzerland)
Prof. Dr. med. Giuseppe Vassalli
CHF 120'000.00
Dissecting critical cellular and molecular mechanisms of acute erythroleukemia
University of Basel, Department of Biomedicine, ZLF, Childhood leukemia
group, Hebelstrasse 20, 4031 Basel, (Switzerland)
Prof. Dr. med. Jürg Schwaller
CHF 120'000.00
Role of IL-33/ST2 signaling in intestinal tumorigenesis
Institute of Pathology, P.O. Box 62, Murtenstrasse 31, 3010 (Switzerland)
Philippe Krebs, PhD
CHF 120’000.00
Co-targeting angiogenesis and immunosuppression to improve cancer therapy
ISREC-EPFL SV, Batiment SV, Station 19-Room SV2527, 1015 Lausanne (Switzerland)
Dr. med . Michele De Palma
CHF 138’000.00.
Dissecting the role of autophagy in normal and malignant B cells towards a rational novel therapeutic target in malignant B cell lymphomas
Inselspital, Universitätsklinik für Medizinische Onkologie, 3010 Bern (Switzerland)
Dr. Urban Nowak
CHF 70’000.00.
A single-arm, phase II trial evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsiv breast cancer who desire pregnancy. Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer (POSITIVE)
University of Bern, Departement of Medical Oncology, Murtenstrasse 35,
3010 Bern (Switzerland)
Dr.ssa Manuela Rabaglio
CHF 216'000.00.
Innate Lympoid Cells (ILCs). A novel effector cell in human cancer
University of Lausanne, Ludwig Center for Cancer Research, Av. Pierre Decker 4,
1005 Lausanne (Switzerland)
Dr.ssa Camilla Jandus-Marone,
CHF 169'000.00.
Inhibition of CD27 and BCR/ABL signaling in leukemia stem cells
Institute for Medical Oncology, Inselspital University Hospital 3010 Bern (Switzerland)
Prof. Dr. med. Adrian Ochsenbein
CHF 110’670.00.
Identification of novel genetic and epigenetic determinants for oncogenic
transformation in patients with systemic mastocytosis
Institute for Research in Biomedicine, Via Vincenzo Vela 6, 6500 Bellinzona
(Switzerland)
Silvia Monticelli, PhD
CHF 129’740.00.
Identification of novel targets in central nervous systeminfiltration in acute T lymphoblastic leukaemia
Institutefor Research in Biomedicine (IRB), 6500 Bellinzona (Switzerland)
Fabio Grassi MD PhD
CHF150’000.00.
The role of MYC in cancer cell invasion and metastasis
Centrepluridisciplinaire d'Oncologie, Rue du Bugnon 46, 1011 Lausanne (Switzerland)
Anita Wolfer MD PhD
CHF 150'000.00.
Mechanism of small cell lung cancer
Divisionof Experimental Oncology, CePO, CHUV and University of Lausanne, Chemin deBoveresses 155, 1066 Epalinges (Switzerland)
Tatiana Petrova PhD
CHF 120'000.00.
Exploring the role of Toll-interacting protein in colitis-associatedcolorectal cancer development
CHUV,BH10-535, Rue du Bugnon 46, 1011 Lausanne (Switzerland)
Dr. Michel Maillard
CHF 120’000.00.
Therole of calretinin in asbestos-induced malignant mesothelioma investigated inthe NF2+/- mouse model
Unitof Anatomy, Dept. Of Medicine, University of Fribourg, Route AlbertGockel 1 1700 Fribourg (Switzerland)
Prof. Beat Schwaller
CHF 85’000.00.
Functional characterization of an 11q24.3 gain contributing to the pathogenesis of diffuse large B cell lymphoma by blocking B-cell maturation Istituto Oncologico di Ricerca, Via Vela 6, 6500 Bellinzona (Switzerland)
Prof. Dr. med. Francesco Bertoni
CHF 231’000.00.
The role of chemokine synergy-inducing molecules in controlling the tumor microenvironment, cell migration and metastasis
Institute for Research in Biomedicine, Via Vela 6, 6500 Bellinzona (Switzerland)
Dr.ssa Mariagrazia Uguccioni
CHF 173’000.00.
PI3K isoforms in melanoma formation and progression.
Institute of Biochemistry & Genetics, Department of Biomedicine, Mattenstrasse 28, Basel (Switzerland).
Romina Marone, PhD
CHF 45,200.00
Functional characterization of endoplasmic reticulum-associated protein degradation regulators implicated in tumor progression.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona (Switzerland).
Maurizio Molinari, PhD
CHF 190,000.00
Analysis of proteins that interact with the CXCR4 receptor in different tissues.
CXCR4 project, request for extension.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona (Switzerland).
Tiziana Apuzzo, PhD
CHF 40,000.00
Exploring tumor-specific genes as potential novel drug targets in colon cancer.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
Pascale Anderle, MD
CHF 59,000.00
Translational research workshop on gastrointestinal tumors.
ESMO (European Society for Medical Oncology) , Lugano-Viganello, (Switzerland).
CHF 50,000.00
Optimization of endocrine therapy for the individualized treatment of breast cancer identification of new parameters as part of the TEXT study by the IBCSG (International Breast Cancer Study Group).
IOSI, Istituto Oncologico della Svizzera Italiana, Lugano-Viganello,(Switzerland).
Olivia Pagani, MD
CHF 280,000.00
Identification of prognostic abnormalities in B-cell chronic lymphocytic leukaemia.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
Francesco Bertoni, MD
CHF 342,000.00
Kinase (PI3K) in cancer – role for lipid compartmentalization.
Institute of Biochemistry & Genetics
Department of Biomedicine, Basel (Switzerland).
Prof. Matthias P. Wymann, PhD
CHF 40,000.00
Squamous cell anal cancer, chemoradiation, resistance predictive molecular markers, immunohistochemistry, fluorescent in situ hybridization gene mutations.
Istituto Cantonale di Patologia, Locarno (Switzerland).
Milo Frattini, MD
CHF 110,000.00
Analysis of proteins that interact with the CXCR4 receptor in different tissues.
CXCR4 project, application for extension.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona (Switzerland).
Tiziana Apuzzo, PhD
CHF 36,776.00
British Columbia Cancer Agency, Vancouver (Canada).
Alden Moccia, MD
CHF 124,000.00
Communication platform on the cancer system developed by the Fondazione Oncologia Lago Maggiore, Locarno (Switzerland) in collaboration with the Institute of Communication and Health of the USI, University of Lugano (Switzerland).
Augusto Pedrazzini, MD
CHF 223,900.00
Cell super-competition and the discovery of novel markers and targets for detection and/or treatment of early stages of cancer.
Istituto Cantonale di Patologia, Locarno (Switzerland).
Davide Soldini, MD, PhD
CHF 29,600.00
Opening of a Microdissection Laser Unit.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
Carlo Catapano, MD
Pascale Anderle Pedone, MD
CHF 295,000.00
2005 San Salvatore Foundation Young Investigator Award
Mifiana Urosevic, MD, Zurich (Switzerland).
CHF 30,000.00
B2-adrenergic receptor influence in dendritic cell-based cancer vaccines.
Istituto Cantonale di Patologia, Locarno (Switzerland).
Georges Jean-Marie Maestroni, MD
CHF 106,900.00
Cellular function of HsPi of HsPI 3-kinase-C2a - assessment of its role in transcription, centrosome integrity and cell cycle regulation.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona (Switzerland).
Prof. Marcus Thelen
CHF 176,958.00
Molecular and biological mechanisms of non-Hodgkin’s lymphoma - growth at extranodal sites.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona (Switzerland).
Mariagrazia Uguccioni, MD
CHF 127,420.00
Cytogenetic studies using the FISH technique.
Istituto Cantonale di Patologia, Locarno (Switzerland).
Luca Mazzucchelli, MD, PhD
CHF 108,000.00
Role of Akt/PKB and pericytes in protecting endothelial cells against tumor necrosis factor-induced apoptosis.
Multidisciplinary Centre for Oncology, Faculty of Medicine, University of Lausanne, Epalinges (Switzerland).
Curzio Rüegg, MD
CHF 137,252.00
2002 San Salvatore Foundation Young Investigator Award
Department of Experimental Hematology, Queen Mary’s Scool of Medicine and Dentistry, London, and
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
Francesco Bertoni, MD
CHF 30,000.00
Ticino Hospice, Lugano (Switzerland).
Development and medical presence in the Sopraceneri region
CHF 102,000.00
Molecular characterization of chromosome 11q in primary extranodal diffuse large B-cell lymphomas.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
Francesco Bertoni, MD
CHF 180,000.00
“Pilot study: Breast cancer database (Carma)”.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
Prof. Aron Goldhirsch, MD
Olivia Pagani, MD
Rossella Graffeo, MD
Prof. Jacques Bernier, MD
CHF 130,000.00
Research in oncological Immunology at Sloan Kettering Cancer Center,
New York (USA).
Camilla Marone, MD
CHF 10,000.00
2001 San Salvatore Foundation Young Investigator Award.
Institute of Anatomy, University of Bern (Switzerland).
Valentin Djonov, MD
CHF 30,000.00
2000 San Salvatore Foundation Young Investigator Awards.
A.F. Ochsenbein, MD
Institute for Medical Oncology, Bern University Hospital (Switzerland).
CHF 20,000.00
Luca Mazzucchelli, MD, PhD
Institute for Pathology, University of Bern (Switzerland).
CHF 20,000.00
Chemokine expression and functions in Hodgkin’s disease.
Institute for Pathology, University of Bern (Switzerland).
Luca Mazzucchelli, MD, PhD
CHF 100,000.00
Analysis of the immunoglobulin heavy chain variable region in nodal marginal zone B-cell lymphoma and lymphoplasmacytoid lymphoma.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
Emanuele Zucca, MD
CHF 25,000.00
Neural influence on dendritic cell generation and function.
Istituto Cantonale di Patologia, Locarno (Switzerland).
Georges Jean-Marie Maestroni, MD
CHF 25,000.00
Registry of unrelated marrow donors.
Transfusion Service of Southern Switzerland, Lugano (Switzerland).
Damiano Castelli, MD
CHF 80,000.00
1999 San Salvatore Foundation Young Investigator Award.
Uwe Zangemeister-Wittke, MD
Oncology Department, University Hospital, Zurich (Switzerland).
CHF 30,000.00
Effect of iNOS Expression on PhlP (a colon carcinogen) induced apoptosis and mutagenicity
Institute of Pharmacology and Toxicology, Lausanne (Switzerland).
Phaik Morgenthaler Leong, MD
CHF 60,000.00
Evaluating extranodal stage I and II low-grade lymphomas of the PMH.
Princess Margaret Hospital,
Department of Radiation Oncology, University of Toronto (Canada).
Thomas Lippuner, MD
CHF 30,000.00
Upgrading of BRCA1 and BRCA2 analysis in Ticino.
Laboratorio Bioanalitico SA, Savosa (Switzerland).
Alberto Pedrazzini, MD
Gianbattista Soldati, MD
CHF 60,000.00
The mitogenic action of phosphoinositide 3-kinases.
Institute of Biochemistry, University of Fribourg (Switzerland).
Matthias Paul Wymann, MD
CHF 40,000.00
Ku 32 gene transfer to augment the radiosensitivity of hamster and human tumour cells.
San Giovanni Hospital, Bellinzona (Switzerland).
J. Bernier, MD, PhD
J. Bourhis, MD
Ch. Badie, MD
CHF 72,233.00
Investigation of the clinical relevance of a novel subunit of the 26S proteasome which confers resistance to antitumour drugs in vitro and is variably expressed in tumour cell lines.
Cantonal Oncological Service, Bellinzona (Switzerland).
Vito Spataro, MD
CHF 24,000.00
Pathological role of cathepsin B in osteoarthritis - splicing of mRNA.
Centre for Experimental Rheumatology,
University of Zurich (Switzerland).
Prof. Antonio Baici, MD
CHF 89,000.00
1998 San Salvatore Foundation Young Investigator Award.
Dermatology Clinic, University Hospital Zurich (Switzerland).
Reihnard Georg Dummer, MD
CHF 30,000.00
Swiss Registry of Marrow Donors, Bern (Switzerland).
CHF 50,000.00
Phage display libraries for the identification of cell-targeting peptides for growth and activation receptors.
Brigham and Women’s Hospital, Department of Pathology, Boston (USA).
Luca Mazzucchelli, MD, PhD
CHF 45,000.00
Characterization and distribution of alpha-1 adrenoceptors in human hematopoietic cells: a basis for new therapeutic strategies in oncology?
Istituto Cantonale di Patologia, Locarno (Switzerland).
Georges Jean-Marie Maestroni, MD
CHF 100,000.00
Study of sterol-regulated proteolytic processing of sterol regulatory element binding protein (SREBP) in vivo.
Southwestern Medical Center, Department of Molecular Genetics, University of Texas, Dallas (USA).
Luca Barella, MD
CHF 25,000.00
Gastric MALT lymphoma as a model of tumour progression: evolution from Helicobacter pylori gastritis to low-grade and high-grade lymphomas.
Cantonal Oncological Service, Bellinzona (Switzerland).
Emanuele Zucca, MD
CHF 150,000.00
Swiss Registry of Marrow Donors, Bern (Switzerland).
CHF 50,000.00
Angiogenesis, tumour neovascularization. Identification of the inhibitor that halts growth in vivo.
Laboratory of Tumor Biology and Genetics, Neurosurgery Service, CHUV, Lausanne (Switzerland).
Erwin G. Van Meir, MD
CHF 82,000.00
Analysis of the lymphocyte antigen receptor in graft-versus-host disease after HLA compatible allotransplantation of bone: one stage in the characterisation of minor histocompatibility antigens.
Cantonal Hospital, Geneva (Switzerland).
Pierre Yves Dietrich, MD
CHF 136,260.00
Graduate course in radiotherapy in France.
Department of Radiotherapy, institut Gustave-Roussy, Villejuif (France).
Susanne Diener, MD
CHF 40,000.00
Interphase cytogenetic analysis by fluorescent non-radioactive in-situ hybridization (FISH method) in the diagnosis and study of centrocytic lymphoma.
San Giovanni Hospital, ”OSG” Ticino Oncological Transplant Foundation,
Bellinzona (Switzerland).
CHF 50,000.00
Graduate course in palliative care at Edmonton (Canada).
Hans Neuenschwander, MD
CHF 30,000.00
Two-year residency at New York Blood Center, New York and the
Department of Laboratory Medicine, Georgetown University Medical
Center, Washington (USA)
Beat M. Frey, MD
CHF 100,000.00
Experiments with genetically modified cells to produce various cytokines at the laboratory of Prof. J.A. Norton, MD, St. Louis (USA)
Gene transfer program
A. Oertli, MD
CHF 40,000.00
Status of information regarding the disease and treatment, depression and anxiety in cancer patients.
University of Geneva (Switzerland).
Marc Archinard, MD
André Haynal, MD
CHF 152,309.00
Istituto Cantonale di Patologia, Locarno (Switzerland).
Ennio Pedrinis, MD
CHF 20,286.00
ATP (adenosin triphosphate) assay. Test of the sensitivity of gynaecological and breast tumours to chemotherapeutic applications.
University Women’s Clinic, Zurich (Switzerland).
Prof. Urs Haller, MD
Ossi R. Koechli, MD
CHF 143,646.00
”Clinical Senology of Lugano” Interdisciplinary Workgroup, Lugano (Switzerland).
Marco Varini, MD
CHF 50,000.00
In vitro assay of intrinsic radioresistance as predictive test of radiocurability
San Giovanni Hospital, Bellinzona (Switzerland)
Civic Hospital, Lugano (Switzerland)
Beata Vergine Hospital, Mendrisio (Switzerland)
La Carità Hospital, Locarno (Switzerland)
Vaudois University Hospital Centre, Lausanne (Switzerland)
CHF 465,000.00
Cancer Atlas of Switzerland (Zurich/Basel).
Swiss Cancer League, Bern (Switzerland).
G. Schüler, MD
M. Bopp, MD
CHF 10,000.00
Tumor Infiltrating Lymphocytes.
Research Division, Dept. of Surgery,
University of Basel (Switzerland).
Michael Heberer, MD, PhD
CHF 260,000.00
The role of pineal gland immunity.
Istituto Cantonale di Patologia, Locarno (Switzerland).
Georges Jean-Marie Maestroni, MD
Ario Conti, MD
CHF 20,000.00
Psychological course of cancer patients.
Psychosomatic and Psychosocial Medical Unit,
University of Geneva (Switzerland).
Marc Archinard, MD
Prof. André Haynal, MD
CHF 140,000.00
Immunological recovery after chemotherapy.
La Carità Hospital, Oncology Service, Locarno (Switzerland).
Augusto Pedrazzini, MD
CHF 100,000.00
Swiss Cancer League
Kisk Committee of the Cancer League on Ionising Radiation and Cancer, Bern, (Switzerland).
CHF. 100,000.00